The Quanterix SR-X Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system. Join us to learn more!
- SR-X assay workflow and processing time
- Multiplexing capabilities
- Benefits of off-line sample preparation
Date: February 7, 2018, 9:00am ET
Speaker: Dr. David Duffy, Chief Technology Officer, Quanterix
David joined Quanterix in 2007 and leads the team of scientists developing its single molecule detection technology. David is an inventor on 12 U.S. patents and has more than 20 publications in the fields of surface chemistry, microfluidics, and bioanalysis.